Novartis Foundation Launches New Leprosy Strategy at Symposium on Disease Elimination
![](/46/pdcnewsitem/03/28/48/Bp6vSsoMxWxf6Am.jpg)
Today's symposium of the Novartis Foundation for Sustainable Development (NFSD) convenes experts to discuss "What does it take to eliminate a disease?" Drawing lessons from previous successful disease control programmes, the symposium speakers discuss innovative approaches and advocate for new co-ordination strategies in disease elimination efforts.
The Novartis Foundation for Sustainable Development today also announces the launch of a new leprosy strategy based on the consensus reached by a group of leading experts earlier this year. The new strategy focuses on interrupting leprosy transmission through early diagnosis and treatment, contact tracing of former patients, diagnostic tools and strict surveillance and response.
"As part of our pledge to fight neglected diseases in the developing world, Novartis and the Novartis Foundation for Sustainable Development are committed to going the last mile to help make leprosy history," says Joseph Jimenez, CEO of Novartis, in an address to the symposium today. "This devastating disease is curable and I am proud that our donation of multidrug therapy (MDT) has helped treat more than five million patients since 2000."
Thanks to the availability of MDT, according to the World Health Organization (WHO), more than 15 million patients have been cured of leprosy since 1981, shrinking the worldwide prevalence by approximately 95%. During the past 8 years, however, the number of newly diagnosed leprosy patients has plateaued at around 230,000 cases per year. As experience with other disease control programmes has shown, going the last mile is often the hardest. Waning knowledge means that as prevalence decreases, so do political will and funding.
"The key to eradicating smallpox was a comprehensive approach including the availability of an effective, heat stable vaccine, epidemiological surveillance, thorough research, involvement of local communities, as well as strong management and commitment by the respective governments," says Professor Donald Henderson, former Head of the WHO's Smallpox Eradication Campaign. "Current elimination programs can also draw on these lessons learned."
CThe Novartis Foundation plans to take steps to demonstrate the feasibility and efficacy of this strategy in several sites in Asia, Africa and Latin America. "Zero transmission of leprosy is achievable, but we need to be better equipped and use innovative approaches if we are to find and treat the last patients," says Ann Aerts, Head of the Novartis Foundation. "In collaboration with our partners, we want to play a key role in curbing the incidence of leprosy."
Related News
-
News CPHI North America 2024 – From the Floor
Welcome to Philly! CPHI North America once again graces the Philadelphia Convention Center, 7–9 May 2024. -
News Women in Pharma: Diversi‘tea’ at CPHI North America
CPHI North America will unite the pharmaceutical supply chain in Philadelphia from May 7–9, 2024 for 3 days of innovation and connections. As part of the content Agenda, our Diversity Track will bring the industry together to discuss the imperati... -
News More to celebrate at the CPHI Milan Pharma Awards 2024
The CPHI Milan Pharma Awards, which are now open for nominations until 18 May 2024, celebrate the innovators making a difference. This year, two new categories have been added to further honour the contributions of a diverse range of pharma professiona... -
News On Track at CPHI NA 2024: Sustainable Futures with Thermo Fisher Scientific
On the 7-9 May 2024 in Philadelphia, CPHI NA will be presenting an unmissable agenda, filled with content across 4 main tracks. In the following interview the Sustainable Futures Track sponsor, Thermo Fisher Scientific gives an overview of what to expe... -
News LEAP-ing into the future of pharma – the CPHI Middle East Vision
On March 6, 2024, the CPHI team hosted the Future of Pharma Forum at LEAP 2024, Saudi Arabia’s premier destination for tech leaders and innovators to meet and collaborate. -
News CPHI Middle East 2024 – What do we have to look forward to?
We’re bringing CPHI to the Middle East in December 2024. CPHI brings together the pharma community from all over the world, creating a platform for education, collaboration, and progress. -
News CPHI Pharma Awards 2023 – Packaging & Machinery Winner: Gasporox
After another year of impressive nominations for the CPHI Pharma Awards our winners were announced at CPHI Barcelona in October 2023. In this series of interviews, we speak to the people and teams behind the award-winning projects, concepts, and techno... -
News Unpacking what we learnt: Key Pharmapack takeaways with L.E.K. Consulting
After another successful Pharmapack show, we sat down with Karin von Kienlin, Senior Partner at L.E.K. Consulting, to discuss the biggest takeaways and surprises from 2 days of intense discussion and collaboration.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance